Markets

Insider Trading

Hedge Funds

Retirement

Opinion

13 Most Oversold Healthcare Stocks So Far in 2025

Page 1 of 11

In this article, we will be taking a look at the 13 Most Oversold Healthcare Stocks So Far in 2025.

The healthcare innovation landscape in 2025 is navigating a complex mix of challenges and opportunities, marked by contrasting trends in fundraising, investment, and technology adoption. In the first half of the year, U.S. healthcare venture capital (VC) fundraising totaled approximately $3 billion, representing a sharp decline and potentially the weakest year for healthcare fundraising in over a decade. This slowdown reflects macroeconomic pressures such as high interest rates, inflation concerns, geopolitical tensions, and policy uncertainties that impact funding and operations. Despite these headwinds, private healthcare markets remain resilient, with notable activity in biopharma mergers, acquisitions, and strategic licensing deals.

Artificial intelligence (AI) has emerged as a bright spot within the sector. Healthtech AI deal volume has nearly doubled since 2022, becoming a key driver of innovation funding. Digital health startups raised $6.4 billion in VC funding in the first half of 2025, up from $6 billion in the same period in 2024, fueled by investor interest in AI solutions that improve clinical decision support, imaging, and operational efficiency. Additionally, China has significantly increased its role in biopharma licensing, spending $3 billion on deals in H1 2025 alone, surpassing total 2024 spending, yet U.S. biopharma investment remains robust.

However, the broader healthcare sector faces substantial pressure. Mizuho healthcare strategist Jared Holz highlighted on CNBC’s “The Exchange” that the industry is under unprecedented strain, with large-cap pharmaceuticals and managed care bearing the brunt. He noted that healthcare has rarely outperformed the market in the past decade except during market downturns and described current conditions as the worst the sector has experienced in decades.

Despite these challenges, strategic acquisitions, early-stage investments, and a potential revival in IPO activity suggest the industry remains primed for innovation. AI-driven solutions are increasingly addressing longstanding inefficiencies, positioning healthcare for growth and transformation even amid funding headwinds. The sector stands at a pivotal crossroads, balancing economic pressures with technology-driven opportunities that could shape its future trajectory.

With these trends in mind, let’s now take a look at the most oversold healthcare stocks in 2025.

Our Methodology 

For our methodology, we first used Stock Analysis’s stock screener to filter for companies with a market capitalization above $2 billion and a Relative Strength Index (RSI) below 40. From this filtered list, we identified the stocks with the lowest RSI values and ranked them in descending order to select the top stocks.

Why are we interested in the stocks that hedge funds pile into? The reason is simple: our research has shown that we can outperform the market by imitating the top stock picks of the best hedge funds. Our quarterly newsletter’s strategy selects 14 small-cap and large-cap stocks every quarter and has returned 373.4% since May 2014, beating its benchmark by 218 percentage points (see more details here).

Here is our list of the 13 most oversold healthcare stocks so far in 2025. 

13. Perrigo Company plc (NYSE:PRGO)

Relative Strength Index (RSI): 35.21 

Perrigo Company plc (NYSE:PRGO), a global leader in consumer self-care products, is sharpening its focus on high-growth, high-margin categories across North America and Europe, and it stands thirteenth on our list among the most oversold stocks. Its portfolio spans pain and sleep aids, nutrition, digestive health, and oral care, with recent gains in OTC store brands signaling competitive strength despite challenging market conditions.

In Q2 2025, Perrigo Company plc (NYSE:PRGO) reported net sales of $1.06 billion, a 0.9% decline year-over-year, influenced by divestitures and exited products, particularly in infant formula and digestive health. The corporation continues to navigate soft seasonal demand in allergy, sun care, and blister care categories, as well as slower-than-expected recovery in infant formula.

Under its “Three-S” strategy—Stabilize, Streamline, and Strengthen- the firm is divesting non-core assets, including the Dermacosmetics business, expected to close in Q1 2026. This move aims to streamline operations, reinforce the balance sheet, accelerate debt reduction, and enable greater focus on its core self-care portfolio.

Operational enhancements, including a global operating model upgrade and strengthened brand-building capabilities, are already contributing to market share gains in key segments. Perrigo Company plc (NYSE:PRGO) is emphasizing innovation and expansion in pain and sleep aids, nutrition, and upper respiratory products, aligning resources with higher-growth categories.

12. AptarGroup, Inc. (NYSE:ATR)

Relative Strength Index (RSI): 35.12 

AptarGroup, Inc. (NYSE:ATR), a global leader in drug delivery and consumer product dosing technologies, highlighted its growth strategy and long-term outlook during its Investor Day on September 9, 2025. Executive presentations emphasized strong momentum in the Pharma segment, driven by rising demand for innovative biologics, injectables, and patient-friendly drug delivery solutions.

In Q2 2025, AptarGroup, Inc. (NYSE:ATR) reported a 6% increase in revenue compared to the prior year, with net income rising 24% to $112 million and adjusted EBITDA up 13%. Earnings per share grew 25%, reflecting operational efficiencies and strong demand across the Pharma and Closures segments.

The company signaled confidence in its sustained performance by announcing a nearly 7% increase in its quarterly dividend to $0.48 per share, marking 32 consecutive years of dividend growth. AptarGroup, Inc. (NYSE:ATR) also returned $100 million to shareholders in dividends and share repurchases during the second quarter, totaling $210 million for the first half of the year, demonstrating a shareholder-friendly capital allocation approach.

11. Danaher Corporation (NYSE:DHR)

Relative Strength Index (RSI): 34.98 

Danaher Corporation (NYSE:DHR), a global leader in life sciences and diagnostics, continues to advance its bioprocessing, diagnostics, and life sciences segments through innovation and strategic partnerships. In Q2 2025, the company marked its eighth consecutive quarter of increased orders in bioprocessing, driven by strong demand for consumables from major pharmaceutical clients. The biotechnology segment saw a 6% year-over-year revenue rise, supported by growing monoclonal antibody demand, while molecular diagnostics contributed to a 2% core revenue increase, led by Beckman Coulter Diagnostics.

Strategic acquisitions have further strengthened Danaher Corporation (NYSE:DHR)’s portfolio. The December 2023 acquisition of Abcam, known for its antibody products, added to Life Sciences segment revenue, reflecting the business’s focus on innovation and diversification. Additionally, the firm is advancing precision medicine through a partnership with AstraZeneca to develop next-generation AI-powered diagnostics, aiming to scale precision healthcare and streamline diagnostic development. As one of the most oversold stocks in the sector, DHR continues to attract attention for its resilience and strategic growth moves.

Danaher Corporation (NYSE:DHR) maintains a shareholder-friendly approach, raising its quarterly dividend by 18.5% to 32 cents per share in early 2025, signaling confidence amid mixed market demand in academic, government, and energy filtration sectors.

Page 1 of 11

The $250 Trillion AI Hype is Real. A few years from now, you’ll probably wish you’d bought this stock.

When Jeff Bezos said that one breakthrough technology would shape Amazon’s destiny, even Wall Street’s biggest analysts were caught off guard.

Fast forward a year and Amazon’s new CEO Andy Jassy described generative AI as a “once-in-a-lifetime” technology that is already being used across Amazon to reinvent customer experiences.

At the 8th Future Investment Initiative conference, Elon Musk predicted that by 2040 there would be at least 10 billion humanoid robots, with each priced between $20,000 and $25,000.

Do the math. According to Musk, this technology could be worth $250 trillion by 2040.

Put another way, that’s roughly equal to:

  • 175 Teslas
  • 107 Amazons
  • 140 Metas
  • 84 Googles
  • 65 Microsofts
  • And 55 Nvidias

And here’s the wild part — this $250 trillion wave isn’t tied to one company, but to an entire ecosystem of AI innovators set to reshape the global economy.

It’s a leap so massive, it could reshape how businesses, governments, and consumers operate worldwide.

Even if that $250 trillion figure sounds ambitious, major firms like PwC and McKinsey still see AI unlocking multi-trillion-dollar potential.

How could anything be worth that much?

The answer lies in a breakthrough so powerful it’s redefining how humanity works, learns, and creates.

And this breakthrough has already set off a frenzy among hedge funds and Wall Street’s top investors.

What most investors don’t realize is that one under-owned company holds the key to this $250 trillion revolution.

In fact, Verge argues this company’s supercheap AI technology should concern rivals.

Before I reveal the details, let’s talk about how some of the richest people on the planet are positioning themselves.

  • Bill Gates sees artificial intelligence as the “biggest technological advance in my lifetime,” more transformative than the internet or personal computer, capable of improving healthcare, education, and addressing climate change.
  • Larry Ellison — through Oracle, is spending billions on Nvidia chips and partnering with Cohere to embed generative AI across Oracle’s cloud and apps.
  • Warren Buffett — not known for tech hype — says this breakthrough could have a ‘hugely beneficial social impact.

When billionaires from Silicon Valley to Wall Street line up behind the same idea — you know it’s worth paying attention to.

Even as we admire what Tesla, Nvidia, Alphabet, and Microsoft have built, we believe an even greater opportunity lies elsewhere…

But the real story isn’t Nvidia — it’s a much smaller company quietly improving the critical technology that makes this entire revolution possible.

And judging by what I’m hearing from both Silicon Valley insiders and Wall Street veterans…

This prediction might not be bold at all:

A few years from now, you’ll wish you’d owned this stock.

The best part? You can discover everything about this company and its groundbreaking technology right now.

I’ve compiled everything you need to know about this groundbreaking company in a detailed, members-only report.

Trust me — you’ll want to read this report before putting another dollar into any tech stock.

For a ridiculously low price of just $9.99 a month, you can unlock a year’s worth of in-depth investment research and exclusive insights – that’s less than a single fast food meal!

Here’s why this is a deal you can’t afford to pass up:

• Access to our Detailed Report on this Game-Changing AI Stock: Our in-depth report dives deep into our #1 AI stock’s groundbreaking technology and massive growth potential.

• 11 New Issues of Our Premium Readership Newsletter: You will also receive 11 new issues and at least one new stock pick per month from our monthly newsletter’s portfolio over the next 12 months. These stocks are handpicked by our research director, Dr. Inan Dogan.

• One free upcoming issue of our 70+ page Quarterly Newsletter: A value of $149

• Bonus Reports: Premium access to members-only fund manager video interviews

• Ad-Free Browsing: Enjoy a year of investment research free from distracting banner and pop-up ads, allowing you to focus on uncovering the next big opportunity.

• 30-Day Money-Back Guarantee:  If you’re not absolutely satisfied with our service, we’ll provide a full refund within 30 days, no questions asked.

If you’re thinking about getting in, don’t wait – because once Wall Street catches wind of this story, the easy money will be gone.

Space is Limited! Only 1000 spots are available for this exclusive offer. Don’t let this chance slip away – subscribe to our Premium Readership Newsletter today and unlock the potential for a life-changing investment.

Here’s what to do next:

1. Head over to our website and subscribe to our Premium Readership Newsletter for just $9.99 a month.

2. Enjoy a year of ad-free browsing, exclusive access to our in-depth report on the revolutionary AI company, and the upcoming issues of our Premium Readership Newsletter over the next 12 months.

3. Sit back, relax, and know that you’re backed by our ironclad 30-day money-back guarantee.

Don’t miss out on this incredible opportunity! Subscribe now and take control of your AI investment future!

No worries about auto-renewals! Our 30-Day Money-Back Guarantee applies whether you’re joining us for the first time or renewing your subscription a month later!

AI, Tariffs, Nuclear Power: One Undervalued Stock Connects ALL the Dots (Before It Explodes!)

Artificial intelligence is the greatest investment opportunity of our lifetime. The time to invest in groundbreaking AI is now, and this stock is a steal!

AI is eating the world—and the machines behind it are ravenous.

Each ChatGPT query, each model update, each robotic breakthrough consumes massive amounts of energy. In fact, AI is already pushing global power grids to the brink.

Wall Street is pouring hundreds of billions into artificial intelligence—training smarter chatbots, automating industries, and building the digital future. But there’s one urgent question few are asking:

Where will all of that energy come from?

AI is the most electricity-hungry technology ever invented. Each data center powering large language models like ChatGPT consumes as much energy as a small city. And it’s about to get worse.

Even Sam Altman, the founder of OpenAI, issued a stark warning:

“The future of AI depends on an energy breakthrough.”

Elon Musk was even more blunt:

“AI will run out of electricity by next year.”

As the world chases faster, smarter machines, a hidden crisis is emerging behind the scenes. Power grids are strained. Electricity prices are rising. Utilities are scrambling to expand capacity.

And that’s where the real opportunity lies…

One little-known company—almost entirely overlooked by most AI investors—could be the ultimate backdoor play. It’s not a chipmaker. It’s not a cloud platform. But it might be the most important AI stock in the US owns critical energy infrastructure assets positioned to feed the coming AI energy spike.

As demand from AI data centers explodes, this company is gearing up to profit from the most valuable commodity in the digital age: electricity.

The “Toll Booth” Operator of the AI Energy Boom

  • It owns critical nuclear energy infrastructure assets, positioning it at the heart of America’s next-generation power strategy.
  • It’s one of the only global companies capable of executing large-scale, complex EPC (engineering, procurement, and construction) projects across oil, gas, renewable fuels, and industrial infrastructure.
  • It plays a pivotal role in U.S. LNG exportation—a sector about to explode under President Trump’s renewed “America First” energy doctrine.

Trump has made it clear: Europe and U.S. allies must buy American LNG.

And our company sits in the toll booth—collecting fees on every drop exported.

But that’s not all…

As Trump’s proposed tariffs push American manufacturers to bring their operations back home, this company will be first in line to rebuild, retrofit, and reengineer those facilities.

AI. Energy. Tariffs. Onshoring. This One Company Ties It All Together.

While the world is distracted by flashy AI tickers, a few smart investors are quietly scooping up shares of the one company powering it all from behind the scenes.

AI needs energy. Energy needs infrastructure.

And infrastructure needs a builder with experience, scale, and execution.

This company has its finger in every pie—and Wall Street is just starting to notice.

Wall Street is noticing this company also because it is quietly riding all of these tailwinds—without the sky-high valuation.

While most energy and utility firms are buried under mountains of debt and coughing up hefty interest payments just to appease bondholders…

This company is completely debt-free.

In fact, it’s sitting on a war chest of cash—equal to nearly one-third of its entire market cap.

It also owns a huge equity stake in another red-hot AI play, giving investors indirect exposure to multiple AI growth engines without paying a premium.

And here’s what the smart money has started whispering…

The Hedge Fund Secret That’s Starting to Leak Out

This stock is so off-the-radar, so absurdly undervalued, that some of the most secretive hedge fund managers in the world have begun pitching it at closed-door investment summits.

They’re sharing it quietly, away from the cameras, to rooms full of ultra-wealthy clients.

Why? Because excluding cash and investments, this company is trading at less than 7 times earnings.

And that’s for a business tied to:

  • The AI infrastructure supercycle
  • The onshoring boom driven by Trump-era tariffs
  • A surge in U.S. LNG exports
  • And a unique footprint in nuclear energy—the future of clean, reliable power

You simply won’t find another AI and energy stock this cheap… with this much upside.

This isn’t a hype stock. It’s not riding on hope.

It’s delivering real cash flows, owns critical infrastructure, and holds stakes in other major growth stories.

This is your chance to get in before the rockets take off!

Disruption is the New Name of the Game: Let’s face it, complacency breeds stagnation.

AI is the ultimate disruptor, and it’s shaking the foundations of traditional industries.

The companies that embrace AI will thrive, while the dinosaurs clinging to outdated methods will be left in the dust.

As an investor, you want to be on the side of the winners, and AI is the winning ticket.

The Talent Pool is Overflowing: The world’s brightest minds are flocking to AI.

From computer scientists to mathematicians, the next generation of innovators is pouring its energy into this field.

This influx of talent guarantees a constant stream of groundbreaking ideas and rapid advancements.

By investing in AI, you’re essentially backing the future.

The future is powered by artificial intelligence, and the time to invest is NOW.

Don’t be a spectator in this technological revolution.

Dive into the AI gold rush and watch your portfolio soar alongside the brightest minds of our generation.

This isn’t just about making money – it’s about being part of the future.

So, buckle up and get ready for the ride of your investment life!

Act Now and Unlock a Potential 100+% Return within 12 to 24 months.

We’re now offering month-to-month subscriptions with no commitments.

For a ridiculously low price of just $9.99 per month, you can unlock our in-depth investment research and exclusive insights – that’s less than a single fast food meal!

Space is Limited! Only 1000 spots are available for this exclusive offer. Don’t let this chance slip away – subscribe to our Premium Readership Newsletter today and unlock the potential for a life-changing investment.

Here’s what to do next:

1. Head over to our website and subscribe to our Premium Readership Newsletter for just $9.99.

2. Enjoy a month of ad-free browsing, exclusive access to our in-depth report on the Trump tariff and nuclear energy company as well as the revolutionary AI-robotics company, and the upcoming issues of our Premium Readership Newsletter.

3. Sit back, relax, and know that you’re backed by our ironclad 30-day money-back guarantee.

Don’t miss out on this incredible opportunity! Subscribe now and take control of your AI investment future!


No worries about auto-renewals! Our 30-Day Money-Back Guarantee applies whether you’re joining us for the first time or renewing your subscription a month later!